Kenvue Stock Hits One-Year Low After Report Says HHS Will Link Tylenol Use In Pregnancy To Autism Risk
According to a report by The Wall Street Journal, the Department of Health and Human Services is likely to release its findings later this month.
Stocktwits·2d ago
More News
J&J Stock Trading Above 200 & 50 Day SMA for 2 Months: Time to Buy?
Johnson & Johnson stock surges above key moving averages as strong results, raised guidance and growth prospects fuel momentum.
Zacks·13d ago
Kenvue (KVUE) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Kenvue (KVUE) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Zacks·1mo ago
Kenvue (KVUE) Q2 Earnings Top Estimates
Kenvue (KVUE) delivered earnings and revenue surprises of +3.57% and -0.51%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
Edgewell Personal Care (EPC) Misses Q3 Earnings and Revenue Estimates
Edgewell Personal (EPC) delivered earnings and revenue surprises of -8.91% and -4.54%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
Palantir, Kenvue, Apple, Intel, Nvidia: What Sparked Heavy After-Hours Trading In These 5 Stocks?
Amid the rise in risk appetite, the S&P 500 Index snapped a four-session decline, ending 1.47% higher.
Stocktwits·1mo ago
Countdown to Kenvue (KVUE) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS
Besides Wall Street's top-and-bottom-line estimates for Kenvue (KVUE), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2025.
Zacks·1mo ago
Apple, Amazon, Nvidia, Intel, Kenvue: What Sparked Heavy After-Hours Trading In These 5 Stocks?
Apple shares climbed in extended trading after surprisingly strong iPhone sales helped the tech giant report its fastest revenue growth since the December quarter of 2021.
Stocktwits·1mo ago
Analysts Estimate Kenvue (KVUE) to Report a Decline in Earnings: What to Look Out for
Kenvue (KVUE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·1mo ago
Should J&J Stock Be in Your Portfolio After Q2 Beat & Guidance Raise?
JNJ jumps over 6% on Q2 earnings beat and full-year guidance increase, driven by strong pharma sales and improved MedTech sales.